Organogenesis Holdings Inc (ORGO) |
|
10.67 0.26 (2.5%)
|
01-27 05:47 |
|
Open: |
10.4 |
Pre. Close: |
10.41 |
|
High:
|
10.89 |
Low:
|
10.2 |
|
Volume:
|
554,014 |
Market Cap:
|
1,363M |
|
|
|
|
Organogenesis Holdings, Inc. is a regenerative medical company. The company is headquartered in Canton, Massachusetts and currently employs 700 full-time employees. The firm focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company also provides integrated healing solutions that substantially improve medical outcomes. The Company’s advanced wound care and surgical & sports medicine products include PuraPly, Antimicrobial (PuraPlyAM), PuraPly, Affinity, NuShield, Apligraf and Dermagraft. The firm is offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. The Company’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
10.9 - 10.953 |
10.953 - 10.999 |
|
Low:
|
10.079 - 10.137 |
10.137 - 10.188 |
|
Close:
|
10.58 - 10.673 |
10.673 - 10.754 |
|
Technical analysis |
as of: 2021-01-26 4:47:21 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 13.00 One year: 15.18 |
| Support: |
Support1: 7.82  Support2: 5.77 |
| Resistance: |
Resistance1: 11.13 Resistance2: 13.00 |
| Pivot: |
8.90 |
| Moving Average: |
MA(5): 10.50 MA(20): 8.51
MA(100): 5.25 MA(250): 4.39 |
| MACD: |
MACD(12,26): 1.20 Signal(9): 1.02 |
| Stochastic oscillator: |
%K(14,3): 85.60 %D(3): 83.29 |
| RSI: |
RSI(14): 74.12 |
| 52-week: |
High: 11.13 Low: 2.47 Change(%): 125.6 |
| Average Vol(K): |
3-Month: 72002 10-Days: 151454 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ORGO has closed below upper band by 17.7%. Bollinger Bands are 263.6% wider than normal. The large width of the bands suggest high volatility as compared to ORGO's normal range. The bands have been in this wide range for 24 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Sun, 24 Jan 2021
Organogenesis Holdings Inc. - Consensus Indicates Potential 50.2% Upside - DirectorsTalk Interviews
Fri, 22 Jan 2021
Organogenesis Holdings Inc. - Consensus Indicates Potential 12.8% Upside - DirectorsTalk Interviews
Thu, 21 Jan 2021
Is Organogenesis Holdings Inc (ORGO) Stock About to Get Hot Thursday? - InvestorsObserver
Wed, 20 Jan 2021
Is Organogenesis Holdings Inc (ORGO) the Top Pick in the Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver
Wed, 20 Jan 2021
Leerink Partners Stick to Their Buy Rating for Organogenesis Holdings Inc By Investing.com - Investing.com
Mon, 18 Jan 2021
Did Organogenesis Holdings' (NASDAQ:ORGO) Share Price Deserve to Gain 80%? - Simply Wall St
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
128 |
| Shares Float (M) |
24 |
|
% Held by Insiders
|
55.51 |
|
% Held by Institutions
|
27.48 |
|
Shares Short (K)
|
320 |
|
Shares Short P. Month (K)
|
508 |
Stock Financials |
|
EPS
|
-0.050 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.610 |
|
Profit Margin
|
-1.61 |
|
Operating Margin
|
1.27 |
|
Return on Assets (ttm)
|
1.1 |
|
Return on Equity (ttm)
|
-12.6 |
|
Qtrly Rev. Growth
|
56.8 |
|
Gross Profit (p.s.)
|
1.449 |
|
Sales Per Share
|
2.397 |
|
EBITDA (p.s.)
|
0.090 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-26 |
|
Levered Free Cash Flow (M)
|
-50 |
Stock Valuations |
|
PE Ratio
|
-213.40 |
|
PEG Ratio
|
|
|
Price to Book value
|
17.49 |
|
Price to Sales
|
4.45 |
|
Price to Cash Flow
|
-52.65 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
